• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

复杂性非典型子宫内膜增生中隐匿性癌症的风险较大。

Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.

机构信息

Anatomic Pathology Unit, Department of Advanced Biomedical Sciences, School of Medicine, University of Naples Federico II, Naples, Italy.

Gynecology and Obstetrics Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Via Sergio Pansini, 5, 80131, Naples, Italy.

出版信息

Arch Gynecol Obstet. 2019 Nov;300(5):1147-1154. doi: 10.1007/s00404-019-05299-2. Epub 2019 Sep 17.

DOI:10.1007/s00404-019-05299-2
PMID:31531779
Abstract

BACKGROUND

In the 2014 WHO classification of endometrial hyperplasia (EH), complex EH is lumped together with simple EH in the benign category of non-atypical EH.

OBJECTIVE

To assess the risk of coexistent cancer in complex EH and simple EH without atypia, through a systematic review and meta-analysis.

METHODS

Electronic databases were searched from their inception to January 2019 for relevant articles.

RESULTS

Twelve studies assessing a total of 804 non-atypical EH were included. The risk of coexistent cancer was significantly higher in complex EH (12.4%) than in simple EH (2%), with an OR of 6.03 (p = 0.0002).

CONCLUSION

Even in the absence of cytologic atypia, complex EH is associated with a significant risk of coexistent cancer. Further studies are necessary to investigate the need for a revision in the WHO classification.

摘要

背景

在 2014 年世界卫生组织(WHO)子宫内膜增生症(EH)分类中,复杂型 EH 与非典型单纯性 EH 一起被归入良性非典型 EH 类别。

目的

通过系统评价和荟萃分析,评估不伴非典型性的复杂型 EH 和单纯型 EH 中同时存在癌症的风险。

方法

从数据库建立之初至 2019 年 1 月,对相关文献进行电子检索。

结果

共纳入 12 项研究,总计 804 例非典型 EH。复杂型 EH(12.4%)同时存在癌症的风险明显高于单纯型 EH(2%),比值比(OR)为 6.03(p=0.0002)。

结论

即使没有细胞学非典型性,复杂型 EH 也与同时存在癌症的风险显著相关。有必要进一步研究以探讨是否需要修订 WHO 分类。

相似文献

1
Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.复杂性非典型子宫内膜增生中隐匿性癌症的风险较大。
Arch Gynecol Obstet. 2019 Nov;300(5):1147-1154. doi: 10.1007/s00404-019-05299-2. Epub 2019 Sep 17.
2
Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.在子宫内膜增生的分类和管理中,应重新考虑腺体结构的复杂性。
APMIS. 2019 Jun;127(6):427-434. doi: 10.1111/apm.12945. Epub 2019 Mar 19.
3
Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer.ARID1A 在子宫内膜增生中的诊断和预后价值:隐匿性癌症的新标志物。
APMIS. 2019 Sep;127(9):597-606. doi: 10.1111/apm.12977.
4
New concepts for an old problem: the diagnosis of endometrial hyperplasia.一个老问题的新概念:子宫内膜增生的诊断。
Hum Reprod Update. 2017 Mar 1;23(2):232-254. doi: 10.1093/humupd/dmw042.
5
Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.子宫内膜增生和癌变进展:哪种分类系统能更好地分层风险?系统评价和荟萃分析。
Arch Gynecol Obstet. 2019 May;299(5):1233-1242. doi: 10.1007/s00404-019-05103-1. Epub 2019 Feb 27.
6
Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.子宫内膜增生与共存癌症的风险:WHO 与 EIN 标准。
Histopathology. 2019 Apr;74(5):676-687. doi: 10.1111/his.13776. Epub 2019 Feb 10.
7
Nuclear expression of β-catenin in endometrial hyperplasia as marker of premalignancy.β-连环蛋白在子宫内膜增生中的核表达作为癌前病变的标志物。
APMIS. 2019 Nov;127(11):699-709. doi: 10.1111/apm.12988. Epub 2019 Sep 11.
8
Diabetes Mellitus Is Associated with Occult Cancer in Endometrial Hyperplasia.糖尿病与子宫内膜增生中的隐匿性癌症有关。
Pathol Oncol Res. 2020 Jul;26(3):1377-1384. doi: 10.1007/s12253-019-00684-3. Epub 2019 Jun 15.
9
PAX2 in endometrial carcinogenesis and in differential diagnosis of endometrial hyperplasia: A systematic review and meta-analysis of diagnostic accuracy.PAX2 在子宫内膜癌发生机制及子宫内膜增生鉴别诊断中的作用:系统评价和诊断准确性的荟萃分析。
Acta Obstet Gynecol Scand. 2019 Mar;98(3):287-299. doi: 10.1111/aogs.13512. Epub 2019 Jan 8.
10
PTEN expression in endometrial hyperplasia and risk of cancer: a systematic review and meta-analysis.PTEN 表达在子宫内膜增生和癌症风险中的作用:系统评价和荟萃分析。
Arch Gynecol Obstet. 2019 Jun;299(6):1511-1524. doi: 10.1007/s00404-019-05123-x. Epub 2019 Mar 26.

引用本文的文献

1
Endometrial Adenocarcinoma After a Benign Biopsy Without Atypia: A Case Report.良性活检未见异型性后发生的子宫内膜腺癌:一例报告
Cureus. 2024 Aug 27;16(8):e67906. doi: 10.7759/cureus.67906. eCollection 2024 Aug.
2
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.子宫内膜癌。德国妇科与产科学会(DGGG)、德国妇科肿瘤学会(DKG)和德国妇科与产科学会(DKH)指南(S3级,德国医学科学院注册编号032/034-OL,2022年9月) - 第2部分,关于癌前病变和早期子宫内膜癌的治疗、手术治疗、放射治疗和药物治疗、随访、复发与转移、心理肿瘤护理、姑息治疗、患者教育以及康复和物理治疗的建议。
Geburtshilfe Frauenheilkd. 2023 Aug 15;83(8):963-995. doi: 10.1055/a-2066-2068. eCollection 2023 Aug.
3
Comparison between Laparoscopic and Robotic Approach for Sentinel Lymph Node Biopsy in Endometrial Carcinoma Women.子宫内膜癌女性前哨淋巴结活检的腹腔镜与机器人手术方法比较
J Pers Med. 2022 Dec 23;13(1):29. doi: 10.3390/jpm13010029.
4
Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia.左炔诺孕酮宫内节育器与口服孕激素对非不典型子宫内膜增生消退效果的比较。
Heliyon. 2022 Dec 7;8(12):e12150. doi: 10.1016/j.heliyon.2022.e12150. eCollection 2022 Dec.
5
Metabolomic analysis of endometrial cancer by high-resolution magic angle spinning NMR spectroscopy.高分辨魔角旋转 NMR 光谱法分析子宫内膜癌的代谢组学。
Arch Gynecol Obstet. 2022 Dec;306(6):2155-2166. doi: 10.1007/s00404-022-06587-0. Epub 2022 May 14.
6
Risk of atypical hyperplasia and endometrial carcinoma after initial diagnosis of non-atypical endometrial hyperplasia: A long-term follow-up study.初次诊断非典型子宫内膜增生后发生非典型增生和子宫内膜癌的风险:一项长期随访研究。
PLoS One. 2022 Apr 12;17(4):e0266339. doi: 10.1371/journal.pone.0266339. eCollection 2022.
7
Diagnostic and prognostic value of Bcl-2 in uterine leiomyosarcoma.Bcl-2 在子宫平滑肌肉瘤中的诊断和预后价值。
Arch Gynecol Obstet. 2023 Feb;307(2):379-386. doi: 10.1007/s00404-022-06531-2. Epub 2022 Mar 28.
8
Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.绝经后出血且接受口服抗凝治疗的患者中,初次诊断为非典型子宫内膜增生后行子宫切除术时发生更高级别病变的风险。
Medicina (Kaunas). 2021 Sep 23;57(10):1003. doi: 10.3390/medicina57101003.
9
Clinical Characteristics of Patients with Endometrial Cancer and Adenomyosis.子宫内膜癌合并子宫腺肌病患者的临床特征
Cancers (Basel). 2021 Sep 30;13(19):4918. doi: 10.3390/cancers13194918.
10
Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments.子宫内膜增生症患者的子宫内膜癌风险因素:对临床治疗的启示。
BMC Womens Health. 2021 Aug 25;21(1):312. doi: 10.1186/s12905-021-01452-9.